Effects of chest physiotherapy and lung squeezing technique in COPD patients
Comparative Effects of Chest Physiotherapy and Lungs Squeezing Technique in Patients With Chronic Obstructive Pulmonary Disease.
This study is testing whether chest physiotherapy and a lung squeezing technique can help people with COPD breathe better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Trial ID | NCT06480435 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the impact of chest physiotherapy and a lung squeezing technique on patients diagnosed with chronic obstructive pulmonary disease (COPD). The study employs a randomized design and utilizes non-probability convenience sampling to gather data. Participants will undergo specific interventions aimed at improving lung function, measured through spirometry. Data analysis will be conducted using SPSS software to assess the effectiveness of the treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are males aged 40-60 years with moderate to severe COPD as per GOLD guidelines.
Not a fit: Patients with unstable cardiovascular diseases, low oxygen saturation, active pulmonary tuberculosis, or neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance respiratory function and quality of life for patients with COPD.
How similar studies have performed: While similar techniques have been explored, this specific combination of chest physiotherapy and lung squeezing technique in COPD patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 40\_60 yrs. old male * COPD diagnosed with GOLD guidelines stage 2 moderate to severe(14) * FEV1/ FVC ratio below 70% * No use of beta 2 receptor agonist or anticholinergic drugs at least 6 hours before attending the study Exclusion Criteria: * unstable cardiovascular diseases * SpO2 at rest below 88% * Active pulmonary Tuberculosis * Neurological disorders
Where this trial is running
Lahore, Punjab Province
- Tehsil Head Quarter Hospital — Lahore, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Sidra Afzal, PP-DPT — Riphah International University
- Study coordinator: Iqbal Tariq, Phd
- Email: iqbal.tariq@riphah.edu.pk
- Phone: 03338236752
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.